Breaking News Instant updates and real-time market news.

ALGN

Align Technology

$213.01

-0.62 (-0.29%)

09:52
10/23/19
10/23
09:52
10/23/19
09:52

Northcoast analysis shows favorable utilization trends for Align's Invisalign

Northcoast analyst David Keiser says that despite a more competitive clear aligner market, his North American Invisalign doctor analysis suggests favorable utilization trends have continued. 13 additional Invisalign doctors in the analyst's sample size reached the four upper tiers of Align Technology's Invisalign Advantage Program, and he also saw a sequential increase of 85 Invisalign doctors in the Silver level of the Invisalign Advantage program. Keiser maintains a Q3 earnings per share estimate of $1.16 for Align Technology, which is 2c ahead of consensus. He reiterates a Buy rating on the shares with a $299 price target.

  • 23

    Oct

ALGN Align Technology
$213.01

-0.62 (-0.29%)

10/07/19
GUGG
10/07/19
DOWNGRADE
Target $200
GUGG
Neutral
Guggenheim downgrades Align Technology on rising competition, sinking sentiment
As previously reported, Guggenheim analyst Glen Santangelo downgraded Align Technology (ALGN) to Neutral from Buy with a price target of $200, down from $250. Santangelo now believes that competition is more aggressive than he originally anticipated after his proprietary channel checks suggested that the technical and service capabilities of the competition, while still "not nearly as good" as Align, may be evolving faster than expected. Many of the established dental companies - such as Dentsply Sirona (XRAY), 3M (MMM), Envista (NVST) and Henry Schein (HSIC) - are offering clear aligners at discounted prices and making a big push in this area, while the direct-to-consumer model has attracted significant attention in the wake of the recent SmileDirectClub (SDC) IPO, Santangelo stated. In all, his view is that sentiment on Align will likely remain challenged until investors fully understand the impact of the new competitive landscape, which may take until later in 2020.
10/07/19
LEHM
10/07/19
NO CHANGE
Target $272
LEHM
Overweight
Barclays clear aligner survey positive for Align Technology
Barclays analyst Steve Valiquette views his clear aligner survey last week to gauge U.S. trends for Q3 as positive for Align Technology. Based on the survey, the analyst believes the U.S. volume outlook looks solid, and his Align Technology revenue growth assumptions of 21% in 2019 and 23% in 2020 are unchanged. Further, respondents indicated there was no notable Invisalign discounting program in Q3 beyond the normal volume-tier discounts, Valiquette tells investors in a research note. The analyst lowered his price target for Align Technology to $272 from $300 and keeps an Overweight rating on the shares.
10/07/19
STFL
10/07/19
NO CHANGE
Target $290
STFL
Buy
Align Technology shares oversold at current levels, says Stifel
Stifel analyst Jonathan Block, who initiated coverage of SmileDirectClub (SDC) with a Buy rating and $19 price target this morning, said in a separate note to investors that he continues to view Align Technology (ALGN) as his preferred name in the clear aligner space. While challenges, such as foreign exchange headwinds and China's macro issues, remain, EMEA has been strong for the company and he "likes what he sees so far" within his proprietary U.S. due diligence, Block tells investors. He views Align shares as oversold at current levels and expects "worst case fears" around Align's share losses to SmileDirect to ease in coming quarters, Block noted. He keeps a Buy rating on Align shares with a $290 price target.
10/17/19
STFL
10/17/19
NO CHANGE
Target $290
STFL
Buy
Align Technology survey results support positive stance, says Stifel
Stifel analyst Jonathan Block said his recent survey work on Align Technology has been favorable and supports his positive stance, with providers citing "solid" Invisalign momentum at their practices, "healthy" 2020 case volume expectations, and little incremental progress from competing traditional clear aligner offerings. His checks also detected some acknowledgement of incremental Invisalign case volume resulting from Align's increased sales force investments, noted Block, who keeps a Buy rating and $290 price target on Align shares.

TODAY'S FREE FLY STORIES

JNPR

Juniper

$25.52

-0.17 (-0.66%)

10:05
11/13/19
11/13
10:05
11/13/19
10:05
Options
Juniper Networks call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

10:05
11/13/19
11/13
10:05
11/13/19
10:05
General news
Treasury Action: the markets were unmoved by the prepared Powell testimony »

Treasury Action: the…

HE

Hawaiian Electric

$43.19

0.04 (0.09%)

10:03
11/13/19
11/13
10:03
11/13/19
10:03
Periodicals
ValueAct calls on Hawaiian Electric to look outside for next CEO, Bloomberg says »

Jeff Ubben, the CEO of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDWR

Radware

$23.32

(0.00%)

10:01
11/13/19
11/13
10:01
11/13/19
10:01
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

RCKT

Rocket Pharmaceuticals

$15.44

(0.00%)

10:00
11/13/19
11/13
10:00
11/13/19
10:00
Conference/Events
Rocket Pharmaceuticals management to meet with Piper Jaffray »

Investor Luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

EOG

EOG Resources

$72.53

-0.76 (-1.04%)

, PXD

Pioneer Natural

$134.51

-1.67 (-1.23%)

09:59
11/13/19
11/13
09:59
11/13/19
09:59
Conference/Events
BofA/Merrill to hold a conference »

Global Energy Conference…

EOG

EOG Resources

$72.53

-0.76 (-1.04%)

PXD

Pioneer Natural

$134.51

-1.67 (-1.23%)

CRC

California Resources

$8.08

-0.06 (-0.74%)

PTEN

Patterson-UTI

$8.72

-0.32 (-3.54%)

SLB

Schlumberger

$35.72

-0.49 (-1.35%)

PE

Parsley Energy

$16.37

-0.28 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

PEGA

Pegasystems

$72.90

(0.00%)

09:58
11/13/19
11/13
09:58
11/13/19
09:58
Conference/Events
Pegasystems management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 10

    Dec

  • 05

    Mar

HE

Hawaiian Electric

$43.27

0.12 (0.28%)

09:58
11/13/19
11/13
09:58
11/13/19
09:58
Hot Stocks
Hawaiian Electric board says ValueAct letter seeking new CEO 'disappointing' »

Jeff Watanabe, Chair of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ILMN

Illumina

$294.99

-0.89 (-0.30%)

09:57
11/13/19
11/13
09:57
11/13/19
09:57
Conference/Events
Illumina participates in a conference call with SVB Leerink »

Conference call with Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$38.05

-0.39 (-1.01%)

09:57
11/13/19
11/13
09:57
11/13/19
09:57
Hot Stocks
Occidental sees proceeds from asset sales of at least $15B by middle of 2020 »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$38.10

-0.34 (-0.88%)

09:55
11/13/19
11/13
09:55
11/13/19
09:55
Hot Stocks
Breaking Hot Stocks news story on Occidental Petroleum »

Occidental sees proceeds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$7.21

0.16 (2.27%)

, TSN

Tyson Foods

$89.50

0.505 (0.57%)

09:55
11/13/19
11/13
09:55
11/13/19
09:55
Options
Early notable gainers among liquid option names on November 13th »

Notable gainers among…

PCG

PG&E

$7.21

0.16 (2.27%)

TSN

Tyson Foods

$89.50

0.505 (0.57%)

XEC

Cimarex Energy

$45.15

0.15 (0.33%)

CME

CME Group

$204.28

2.74 (1.36%)

KSU

Kansas City Southern

$152.51

0.15 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 07

    Jan

09:55
11/13/19
11/13
09:55
11/13/19
09:55
Conference/Events
Senate Health, Ed, Labor & Pensions Committee to hold a hearing »

The Committee holds a…

09:55
11/13/19
11/13
09:55
11/13/19
09:55
Conference/Events
House Permanent Select Committee on Intelligence to hold a hearing »

The Committee holds a…

OVID

Ovid Therapeutics

$2.47

0.01 (0.41%)

09:54
11/13/19
11/13
09:54
11/13/19
09:54
Conference/Events
Ovid Therapeutics management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

NUE

Nucor

$55.09

-0.23 (-0.42%)

09:52
11/13/19
11/13
09:52
11/13/19
09:52
Conference/Events
Nucor management to meet with KeyBanc »

Management participates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

09:52
11/13/19
11/13
09:52
11/13/19
09:52
Conference/Events
House Judiciary Committee to hold a hearing »

The Subcommittee on…

09:50
11/13/19
11/13
09:50
11/13/19
09:50
General news
Fed Chair Powell's said policy is appropriate as long as the economy remains on track »

Fed Chair Powell's…

NSSC

Napco Security

$28.01

(0.00%)

09:49
11/13/19
11/13
09:49
11/13/19
09:49
Conference/Events
Napco Security management to meet with Oppenheimer »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MRNA

Moderna

$17.96

-0.03 (-0.17%)

09:48
11/13/19
11/13
09:48
11/13/19
09:48
Conference/Events
Moderna management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HZN

Horizon Global

$3.72

-0.04 (-1.06%)

09:47
11/13/19
11/13
09:47
11/13/19
09:47
Hot Stocks
Horizon Global falls -6.9% »

Horizon Global is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$4.52

-0.115 (-2.48%)

09:47
11/13/19
11/13
09:47
11/13/19
09:47
Hot Stocks
SandRidge Energy falls -7.5% »

SandRidge Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

I

Intelsat

$18.47

-1.92 (-9.42%)

09:47
11/13/19
11/13
09:47
11/13/19
09:47
Hot Stocks
Intelsat falls -11.9% »

Intelsat is down -11.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SPB

Spectrum Brands

$55.94

4.75 (9.28%)

09:47
11/13/19
11/13
09:47
11/13/19
09:47
Hot Stocks
Spectrum Brands rises 9.1% »

Spectrum Brands is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LN

Line Corp.

$40.67

(0.00%)

09:47
11/13/19
11/13
09:47
11/13/19
09:47
Hot Stocks
Line Corp. rises 13.0% »

Line Corp. is up 13.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.